Recent Company News

• 09:42 PM ET Jul 20, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 04:58 PM ET Aug 04, 2025
  

  Mesoblast initiated buy at Canaccord Genuity (A$2.37, 0.00)

• 09:16 AM ET Aug 01, 2025
  

  Spine BioPharma (private) announces phase 3 trial fails to meet primary endpoint in CLBP; sham control response issues noted

• 08:43 PM ET Jul 20, 2025
  

  Street Takeaways - Mesoblast Q4 update (A$2.22, -0.19)

• 09:18 AM ET Jul 18, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:21 AM ET Jul 18, 2025
  

  StreetAccount Summary - US Pre-market trading